SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Home ▸ Development ▸ Forging partnerships for success with strategic outsourcing
Home ▸ Development ▸ Forging partnerships for success with strategic outsourcing
Home ▸ Development ▸ Forging partnerships for success with strategic outsourcing
In today’s rapidly evolving global economy, businesses are under constant pressure to innovate, scale, and stay competitive. Traditional cost-cutting measures are no longer sufficient. Instead, strategic outsourcing has emerged as a powerful lever for growth—especially in the life sciences sector.
This session will delve into:
Whether you’re a biotech startup or an established pharmaceutical company, this webinar will provide valuable insights into leveraging outsourcing as a strategic advantage in a competitive landscape.
Join us for an insightful webinar exploring the rise of strategic outsourcing and its transformative impact on the biologics industry. With the Biologics CDMO market projected to grow from $10.59 billion in 2024 to $16.36 billion by 2030, organizations—particularly virtual and lean enterprises—are increasingly turning to Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) to access specialized expertise, accelerate timelines, and reduce infrastructure costs.
© 2023. Syngene International Limited